日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spatial Distribution and Prognostic Value of T Cell Subtypes and Immune Biomarkers in p16-Negative HNSCC.

p16阴性头颈部鳞状细胞癌中T细胞亚型和免疫生物标志物的空间分布及预后价值

Krum David, Rösch Saskia, Warta Rolf, Mogler Carolin, Yılmaz Topçuoğlu Miray-Su, Grabe Niels, Schuler Patrick J, Dyckhoff Gerhard, Herold-Mende Christel

An Above-Average Lymph Node Yield Removed During Curative Neck Dissection in Advanced Head and Neck Squamous Cell Carcinomas Improves Survival

在晚期头颈部鳞状细胞癌的根治性颈部淋巴结清扫术中,切除的淋巴结数量高于平均水平可提高生存率。

Yılmaz Topçuoğlu, Miray-Su; Seidler, Thiemo; Schuler, Patrick J; Herold-Mende, Christel; Warta, Rolf; Dyckhoff, Gerhard

Combined Spatial and Dosimetric Recurrence Pattern Analysis in Head and Neck Squamous Cell Carcinoma Following Postoperative (Chemo)radiotherapy

头颈部鳞状细胞癌术后(化疗)放疗后空间和剂量学复发模式的联合分析

Schröter, Philipp; Lau, Hoi Hin; Stritzke, Florian; Franke, Henrik; Weusthof, Katharina; Regnery, Sebastian; Bauer, Lukas; Deng, Maximilian; Dvornikovich, Katharina; Hofmann, Anna; Wessel, Lars; Semmelmayer, Karl; Moratin, Julius; Ristow, Oliver; Hoffmann, Jürgen; Plinkert, Peter; Dyckhoff, Gerhard; Debus, Jürgen; Held, Thomas

Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma

人类白细胞抗原作为头颈部鳞状细胞癌的预后标志物

Dyckhoff, Gerhard; Herold-Mende, Christel; Scherer, Sabine; Plinkert, Peter K; Warta, Rolf

Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability

早期声门癌的强度调控质子治疗:高精度喉功能保护方法,具有极佳的治疗耐受性

Held, Thomas; Franke, Henrik; Lang, Kristin; Eichkorn, Tanja; Regnery, Sebastian; Weusthof, Katharina; Bauer, Lukas; Plath, Karim; Dyckhoff, Gerhard; Plinkert, Peter K; Harrabi, Semi B; Herfarth, Klaus; Debus, Jürgen; Adeberg, Sebastian

[Larynx preservation: recommendations for decision-making in T3 laryngeal cancer patients]

[喉保留:T3期喉癌患者决策建议]

Dyckhoff, Gerhard; Warta, Rolf; Herold-Mende, Christel; Plinkert, Peter K; Ramroth, Heribert

[Larynx preservation up to T4 laryngeal cancer?]

[喉癌T4期之前能否保留喉部功能?]

Dyckhoff, Gerhard; Warta, Rolf; Herold-Mende, Christel; Plinkert, Peter K; Ramroth, Heribert

Chemoradiotherapy but Not Radiotherapy Alone for Larynx Preservation in T3. Considerations from a German Observational Cohort Study

对于T3期喉癌患者,采用放化疗而非单纯放疗来保留喉功能:一项德国观察性队列研究的启示

Dyckhoff, Gerhard; Warta, Rolf; Herold-Mende, Christel; Winkler, Volker; Plinkert, Peter K; Ramroth, Heribert

Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients

T2期声门癌患者接受初始放化疗能否取得与T1期患者接受初始放疗相当的疗效?来自531例德国早期患者的思考

Dyckhoff, Gerhard; Warta, Rolf; Herold-Mende, Christel; Rudolph, Elisabeth; Plinkert, Peter K; Ramroth, Heribert

An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment

一项针对 194 例声门上癌患者的观察性队列研究:激光手术和辅助治疗的意义

Dyckhoff, Gerhard; Warta, Rolf; Herold-Mende, Christel; Rudolph, Elisabeth; Plinkert, Peter K; Ramroth, Heribert